Related Experiment Video

Updated: Apr 2, 2026

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
09:58

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Published on: June 27, 2020

3.2K

The oncogenic FIP1L1-PDGFRα fusion protein displays skewed signaling properties compared to its wild-type PDGFRα

Serge Haan1, Christelle Bahlawane1, Jiali Wang1

  • 1Molecular Disease Mechanisms Group; Life Sciences Research Unit; University of Luxembourg; Luxembourg , Luxembourg.

JAK-STAT
|September 29, 2015
PubMed

Insights

The oncogenic FIP1L1-PDGFRα kinase activates STAT factors through a novel, non-canonical mechanism, distinct from wild-type PDGFRα signaling. This aberrant kinase activation bypasses traditional signaling pathways, offering new insights into cancer development.

Area of Science:

  • Molecular Biology
  • Oncology
  • Signal Transduction

Background:

  • Aberrant activation of oncogenic kinases is a hallmark of human cancers, yet the precise signaling mechanisms remain unclear.
  • Understanding how oncogenic kinases like FIP1L1-PDGFRα alter cellular signaling is crucial for developing targeted cancer therapies.

Purpose of the Study:

  • To elucidate the distinct signaling patterns induced by the oncogenic FIP1L1-PDGFRα kinase compared to its wild-type counterpart.
  • To investigate the non-canonical mechanisms underlying STAT factor activation by FIP1L1-PDGFRα.

Main Methods:

  • Comparative analysis of signaling pathways activated by FIP1L1-PDGFRα and wild-type PDGFRα.
  • Investigation of the role of kinase localization (cytoplasmic vs. membrane) in FIP1L1-PDGFRα signaling.
  • Assessment of Janus kinase (JAK) and Src kinase activity in FIP1L1-PDGFRα-mediated STAT activation.
  • Examination of the binding and phosphorylation mechanisms involved in STAT5 activation by FIP1L1-PDGFRα.

Main Results:

  • FIP1L1-PDGFRα exhibits a unique signaling profile, shifting activation from membrane-associated pathways (PI3K, MAPK) towards prominent STAT factor activation.
  • Cytoplasmic localization of FIP1L1-PDGFRα contributes to its altered signaling; membrane targeting restores MAPK and PI3K pathway activation.
  • STAT activation by FIP1L1-PDGFRα is independent of JAK and Src kinase activity.
  • STAT5 activation by FIP1L1-PDGFRα occurs via a non-canonical mechanism, potentially involving direct phosphorylation, not SH2-domain binding.

Conclusions:

  • The oncogenic FIP1L1-PDGFRα kinase employs a non-canonical signaling mechanism, distinct from classical PDGF-receptor signaling, leading to aberrant STAT activation.
  • This aberrant signaling, partly due to cytoplasmic localization, bypasses conventional kinase requirements, highlighting a novel oncogenic mechanism.
  • The findings suggest direct phosphorylation of STAT5 by FIP1L1-PDGFRα as a potential non-canonical activation pathway, offering new therapeutic targets in cancer.
Keywords:
AKTFIP1L1-PDGFRαJanus kinaseMAP kinasePlatelet-derived growth factorSH2-domainSTAT-factorSrc kinase

More Related Videos

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing09:49

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Published on: July 5, 2019

10.1K
Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line06:24

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Published on: April 11, 2025

987

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
12.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.3K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.5K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
19.5K